These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9508582)

  • 1. [Management of pulmonary circulation: mechanism of action of vasoactive substances].
    Yokochi A; Maruyama J; Maruyama K
    Masui; 1997 Nov; 46 Suppl():S36-41. PubMed ID: 9508582
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary hypertension: physiologic or pathologic disease?
    Soifer SJ
    Crit Care Med; 1993 Sep; 21(9 Suppl):S370-4. PubMed ID: 8365235
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled nitric oxide for perioperative management of an adult patient with atrial septal defect and severe pulmonary hypertension.
    Kim JH; Ham BM; Kim YL; Ahn H; Noh CI
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):746-8. PubMed ID: 12486659
    [No Abstract]   [Full Text] [Related]  

  • 4. Con: Inhaled nitric oxide should not be used routinely in patients undergoing lung transplantation.
    McQuitty CK
    J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):790-2. PubMed ID: 11748535
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled nitric oxide and pulmonary vascular resistance.
    Bigatello LM; Hurford WE
    Crit Care Med; 1999 Sep; 27(9):2060-1. PubMed ID: 10507659
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nitric oxide inhalation in newborn infants with pulmonary hypertension].
    de Beaufort AJ; Slot HM; van Bel F
    Ned Tijdschr Geneeskd; 1998 Jan; 142(3):123-7. PubMed ID: 9557009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide inhalation selectively attenuates pulmonary hypertension and arterial hypoxia in porcine endotoxin shock.
    Weitzberg E; Rudehill A; Alving K; Lundberg JM
    Acta Physiol Scand; 1991 Dec; 143(4):451-2. PubMed ID: 1815479
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure.
    Miyaji K; Nagata N; Miyamoto T; Kitahori K
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):437-9. PubMed ID: 12579126
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary vascular responses to inhalation anaesthesia in isolated dog lungs.
    Dubikaitis AYu ; Beliakov NA; Simbirtsev SA
    Cor Vasa; 1980; 22(5):384-92. PubMed ID: 7471753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic assessment of vasculopathies in pulmonary hypertension.
    Pietra GG; Capron F; Stewart S; Leone O; Humbert M; Robbins IM; Reid LM; Tuder RM
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):25S-32S. PubMed ID: 15194175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute administration of l-arginine restores nitric oxide-mediated relaxation in isolated pulmonary arteries from pulmonary hypertensive exercise trained rats.
    Goret L; Tanguy S; Guiraud I; Dauzat M; Obert P
    Eur J Pharmacol; 2008 Feb; 581(1-2):148-56. PubMed ID: 18164288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An experiment study of reversed pulmonary hypertension with inhaled nitric oxide on smoke inhalation injury].
    Qi S; Yang Z; He B
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):56-8. PubMed ID: 10374512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary hypertension: the role of nitric oxide in adults].
    Neidecker J
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):457-9. PubMed ID: 11792299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of nitrogen and nitric oxide to control pulmonary blood flow in the Norwood operation.
    Maegawa Y; Mizobe T; Yamagishi M; Shime N; Tanaka Y
    J Cardiothorac Vasc Anesth; 2002 Apr; 16(2):264-6. PubMed ID: 11957186
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhaled nitric oxide through a noninvasive ventilation device to assess reversibility of pulmonary hypertension in selecting recipients for heart transplant.
    Fojón S; Fernández-González C; Sánchez-Andrade J; López-Pérez JM; Hermida LF; Rodríguez JA; Juffé A
    Transplant Proc; 2005 Nov; 37(9):4028-30. PubMed ID: 16386617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Arginine inhibiting pulmonary vascular remodelling is associated with promotion of apoptosis in pulmonary arterioles smooth muscle cells in broilers.
    Tan X; Pan JQ; Li JC; Liu YJ; Sun WD; Wang XL
    Res Vet Sci; 2005 Dec; 79(3):203-9. PubMed ID: 16054890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
    Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
    Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.